Interview study identified categories in which improved psychological support services are needed for these patients.
Investigators of the longitudinal cohort study evaluated follow-up gastroscopy results from patients who underwent surveillance 3 years after receiving a diagnosis of autoimmune or multifocal atrophic gastritis.
If the current COVID-19 trends persist, the NCI estimates that the pandemic’s impact could threaten the trend of annually decreasing cancer mortality seen in the US since 1990.
Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins.
Vitamin D supplementation was associated with a reduction in the incidence of advanced cancer, with the strongest reduction seen in those with normal weight.
Data from the phase-3 investigation of avelumab vs chemotherapy as maintenance therapies for the treatment of gastric or gastroesophageal junction cancer were published in the Journal of Clinical Oncology.
Five Prime Therapeutics, Inc. announced topline data from the phase 2 FIGHT study comparing bemarituzumab and chemotherapy with chemotherapy alone.
Investigators compared the efficacy of linked color imaging and white light imaging in detecting neoplastic lesions in the upper gastrointestinal tract.
Investigators evaluated the impact of insurance status on gastric cancer survival outcomes in patients treated at a safety-net hospital.
The supplemental Biologics License Application includes data from the open-label, randomized phase 2 DESTINY-Gatric01 trial.
A global consensus meeting was convened to go over current evidence and knowledge gaps and propose collaborative studies on population-wide screening and eradication of Helicobacter pylori for the prevention of gastric cancer (GC).
Modest delays in cancer surgery due to the COVID-19 pandemic could have a significant impact on survival.
About one in four cases of colorectal cancer in patients aged 40 to 49 years meet family history-based criteria for early screening.
The American Gastroenterological Association recently published new clinical practice guidelines on the management of gastric intestinal metaplasia.
Although the use of value pathways in oncology appeared to extend time to treatment failure, it did not appear to influence overall survival.
In this interim analysis, PFS rates were compared in PD-L1–defined biomarker subsets of patients receiving maintenance durvalumab or capecitabine.
About 170 visitors and employees at Yosemite National Park have been hit by gastrointestinal illness, park officials say.
The FDA has approved Ayvakit (avapritinib; Blueprint Medicines Corporation), a tyrosine kinase inhibitor, for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.
Unexpectedly identifying a patient as a CDH1 carrier can lead to a “difficult conundrum” for clinicians and patients, highlighting the need for pretest counseling.
The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer.